Ajooni Biotech

₹6.5 0 | 0.8%

WEBSITE BSE:0 NSE : 18 May, 12:47

Market Cap ₹114 Cr.

Stock P/E 42.0

P/B 1.3

Current Price ₹6.5

Book Value ₹ 4.9

Face Value 2

52W High ₹6.9

Dividend Yield 0%

52W Low ₹ 3.4

Edit Ratio

Ajooni Biotech Research see more...

Overview Inc. Year: 2010Industry: Animal Feed

Ajooni Biotech Ltd is an India-based organisation. The Company is engaged in manufacturing, producing, processing and supplying of farm animals feed, and vitamins supplements. The Company's products portfolio consists of Autus Animal Healthcare and Patanjali. Autus animal healthcare, which incorporates farm animals feed and feeds supplements. Patanjali, which gives Patanjali Silver Ration, Patanjali Gold Chips, Patanjali Gold Plus Chips, Patanjali Diamond Chips, Patanjali Energy Rich Supplements, And Patanjali Minvit.

Ajooni Biotech Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Ajooni Biotech Quarterly Results

#(Fig in Cr.)	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Jun 2023	Sep 2023	Dec 2023
Net Sales	16	18	19	21	12	10	11	21	19	20
Other Income	0	0	0	0	0	0	0	0	0	2
Total Income	16	18	19	21	12	10	11	21	20	22
Total Expenditure	15	17	18	20	12	10	10	20	19	21
Operating Profit	1	1	1	0	1	1	0	1	1	1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	0	1	0	0	0	0	0	1	1
Provision for Tax	0	0	0	0	0	0	-0	-0	0	0
Profit After Tax	0	0	0	-0	0	0	0	0	0	0
Adjustments	0	0	0	0	-0	-0	0	-0	0	0
Profit After Adjustments	0	0	0	-0	0	0	0	0	0	0
Adjusted Earnings Per Share	0.1	0.1	0.1	-0	0.1	0	0	0	0	0.1

Ajooni Biotech Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	0	1	7	13	29	42	40	40	51	74	74	71
Other Income	0	0	0	0	0	0	0	0	0	0	0	2
Total Income	0	1	7	13	29	43	40	40	51	74	75	74
Total Expenditure	0	1	7	13	28	41	39	39	49	71	72	70
Operating Profit	-0	0	0	0	1	1	1	1	2	3	3	3
Interest	0	0	0	0	0	0	0	0	1	1	0	0
Depreciation	0	0	0	0	0	0	0	0	1	1	1	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	-0	0	0	0	0	0	0	0	1	1	2	2
Provision for Tax	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-0	0	0	0	0	0	0	0	0	1	1	0
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-0	0	0	0	0	0	0	0	0	1	1	0
Adjusted Earnings Per Share	-0.1	0	0.2	0.3	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	0%	23%	12%	0%
Operating Profit CAGR	0%	44%	25%	0%
PAT CAGR	0%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	43%	-7%	22%	NA%
ROE Average	4%	4%	4%	8%
ROCE Average	6%	7%	6%	10%

Ajooni Biotech Balance Sheet

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	0	1	1	11	12	16	16	16	42
Minority's Interest	0	0	0	0	0	0	0	0	0
Borrowings	0	0	1	0	4	1	2	3	2
Other Non-Current Liabilities	0	-0	3	2	-0	-0	-0	-0	-0
Total Current Liabilities	1	2	8	6	2	6	10	10	15
Total Liabilities	2	2	13	19	18	23	28	29	58
Fixed Assets	0	0	1	1	1	2	4	6	6
Other Non-Current Assets	0	0	6	7	5	3	3	1	17
Total Current Assets	1	2	6	11	12	18	21	22	35
Total Assets	2	2	13	19	18	23	28	29	58

Ajooni Biotech Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	0	0	5	1	0	0	0
Cash Flow from Operating Activities	-0	-0	0	-1	-5	-4	1	4	-6
Cash Flow from Investing Activities	0	-0	-0	-0	1	0	-3	-2	-16
Cash Flow from Financing Activities	0	0	0	1	-1	3	2	-2	22
Net Cash Inflow / Outflow	-0	0	0	-0	-5	-1	0	-0	0
Closing Cash & Cash Equivalent	0	0	0	0	1	0	0	0	0

Ajooni Biotech Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	-0.07	0.02	0.2	0.27	0.55	0.12	0.12	0.07	0.07	0.21	0.13
CEPS(Rs)	-0.07	0.02	0.29	0.47	0.93	0.22	0.25	0.18	0.19	0.43	0.24
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	0.47	0.98	1.18	1.45	1.92	3.19	3.43	3.34	3.1	3.27	4.76
Core EBITDA Margin(%)	0	2.05	1.83	1.74	2.34	2.19	1.78	3.02	3.23	4.15	3.71
EBIT Margin(%)	0	2.12	1.49	1.22	1.84	1.97	1.53	2.02	2.13	2.7	2.76
Pre Tax Margin(%)	0	2.02	1.46	1.07	1.36	1.15	1.2	1.2	0.99	1.97	2.12
PAT Margin (%)	0	1.35	1.01	0.73	0.97	0.91	1.03	0.87	0.73	1.42	1.51
Cash Profit Margin (%)	0	1.37	1.45	1.27	1.64	1.65	2.14	2.1	1.86	2.92	2.86
ROA(%)	-13.51	3.04	6.89	4.78	3.61	2.4	2.2	1.69	1.47	3.7	2.58
ROE(%)	-13.89	4.28	18.72	20.38	36.98	6.8	3.72	2.54	2.4	6.58	3.87
ROCE(%)	-13.89	6.73	27.57	18.62	36.19	10.03	3.84	4.35	5.07	9.09	5.99
Receivable days	0	60.44	22.49	27.7	16.1	17.94	35.36	79.67	94.23	67.91	84.26
Inventory Days	0	109.08	13.4	10.6	29.6	26.78	32.48	38.09	30.97	27.75	31.55
Payable days	0	52.3	36.96	31.05	45.37	29.93	10.48	16.19	31.11	34.78	46.94
PER(x)	0	0	0	0	0	37.96	23.11	14.32	63.36	49.93	27.12
Price/Book(x)	0	0	0	0	0	1.41	0.81	0.32	1.52	3.2	0.73
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0	0.25	0.01	0.07	0.03	0.43	0.41	0.28	0.72	0.98	0.53
EV/Core EBITDA(x)	-2.6	11.76	0.75	4.07	1.19	15.86	15.57	8.68	22.19	23.34	12.9
Net Sales Growth(%)	0	0	1166.04	83.46	115.71	48.51	-6.27	0.79	27.49	45.06	0.61
EBIT Growth(%)	0	1310	785.95	50.37	224.98	59.38	-27.43	33.45	34.59	83.88	2.69
PAT Growth(%)	0	870	845.45	32.55	185.79	40	6.45	-15.62	7.57	181.14	7.24
EPS Growth(%)	0	132.77	845.45	32.55	103.17	-78.26	1.26	-38.2	0.44	180.97	-38.74
Debt/Equity(x)	0	0	0	1.5	0.64	0.45	0.41	0.32	0.44	0.33	0.12
Current Ratio(x)	37	2.67	1.19	1.25	0.73	1.87	6.14	3	2.05	2.18	2.28
Quick Ratio(x)	37	1.5	0.89	1	0.22	1.56	3.54	2.43	1.53	1.6	1.82
Interest Cover(x)	0	20.17	63.06	7.94	3.84	2.41	4.63	2.47	1.86	3.71	4.3
Total Debt/Mcap(x)	0	0	0	0	0	0.25	0.39	0.79	0.22	0.08	0.15

Ajooni Biotech Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	52.62	52.62	52.62	32.41	36.39	36.39	30.29	27.46	26.44	26.44
FII	0	0	0	0.24	0.01	0.01	0	0	0	0
DII	4.26	4.26	0	0	0	0	0	0	0	0
Public	43.12	43.12	47.38	67.36	63.6	63.6	69.71	72.54	73.56	73.56
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.53	0.53	0.53	0.32	3.19	3.19	2.65	2.41	2.32	2.32
FII	0	0	0	0	0	0	0	0	0	0
DII	0.04	0.04	0	0	0	0	0	0	0	0
Public	0.43	0.43	0.47	0.67	5.57	5.57	6.11	6.36	6.45	6.45
Others	0	0	0	0	0	0	0	0	0	0
Total	1	1	1	1	8.76	8.76	8.76	8.76	8.76	8.76

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Promoter holding is low: 26.44%.
Company has a low return on equity of 4% over the last 3 years.
Debtor days have increased from 34.78 to 46.94days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Ajooni Biotech News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Ajooni Biotech

Add Watchlist

Ajooni Biotech Research see more...

Overview Inc. Year: 2010Industry: Animal Feed

Ajooni Biotech Share Price

Alert Data

Quarterly Price

Peer Comparison

Ajooni Biotech Quarterly Results

Ajooni Biotech Profit & Loss

Growth Rates

Ajooni Biotech Balance Sheet

Ajooni Biotech Cash Flow

Ajooni Biotech Ratios

Ajooni Biotech Shareholding Pattern

Ajooni Biotech News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!